Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of provider type on hepatitis C outcomes with boceprevir-based and telaprevir-based regimens.

Journal of clinical gastroenterology - 1 Apr 2015

Backus Lisa I, Belperio Pamela S, Shahoumian Troy A, Mole Larry A

Abstract excerpt

GOALS: To examine the effect of provider type on outcomes and safety in a large hepatitis C virus (HCV)-infected cohort treated in routine medical practice. BACKGROUND: Nonphysician providers (NPP) are uniquely positioned to expand health care infrastructure to meet HCV treatment demands. STUDY: Retrospective, observational cohort analysis of 820 HCV genotype 1-infected veterans initiated on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Health Personnel
Share to Hematologic Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Oligopeptides

Share to Proline

Share to Veterans

Share to Viral Load

Source

Identifiers

PMID: 24667591
DOI: 10.1097/MCG.0000000000000124

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Impact of provider type on hepatitis C outcomes with boceprevir-based and telaprevir-based regimens.PMID 24667591Read ↗

Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.Semantic proximity Read ↗

A survey of hepatitis C treatment clinical practice patterns using the newly approved protease inhibitors.Semantic proximity Read ↗

Quality of care in patients with chronic hepatitis C virus infection: a cohort study.Semantic proximity Read ↗

Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.Semantic proximity Read ↗

Use of specialty care versus standard retail pharmacies for treatment of hepatitis C.Semantic proximity Read ↗

Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders.Semantic proximity Read ↗

Outcomes of chronic hepatitis C therapy in patients treated in community versus academic centres in Canada: final results of APPROACH (a prospective study of peginterferon alfa-2a and ribavirin at academic and community centres in Canada).Semantic proximity Read ↗

Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?Semantic proximity Read ↗

Treat early or wait and monitor? A qualitative analysis of provider hepatitis C virus treatment decision-making in the context of HIV coinfection.Semantic proximity Read ↗

Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.